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Abstract
The aim of this study was to explore the relationship between obesity-related hormone peptides and quality of life 
in obese women among different traditional Chinese medicine (TCM) syndrome groups (證型 zhèng xíng). 260 
obese women met with age between 20 and 65 years old and body mass index (BMI) ≧ 27 kg/m2, were recruited. 
The participants filled out a questionnaire on obese TCM syndrome groups, which was designed by professional 
TCM doctors, and two questionnaires on quality of life (QOL), WHOQOL-BREF Taiwan version and MOS Short 
Form-12 (SF-12). Data of biochemical characteristics and obesity-related hormone peptides were collected at the same 
time. According to the responses provided, the obese subjects were classified into spleen deficiency with dampness 
encumbrance syndrome (脾虛濕阻證 pí xū shī zǔ zhèng; SDD), stomach heat with dampness encumbrance syndrome 
(胃熱濕阻證 wèi rè shī zǔ zhèng; SHD), liver depression and qi stagnation syndrome (肝鬱氣滯證 gān yù qì zhì zhèng; 
LDQ), dual spleen-kidney deficiency syndrome (脾腎兩虛證 pí shèn liǎng xū zhèng; SKD), yin deficiency with internal 
heat syndrome (陰虛內熱證 yīn xū nèi rè zhèng; YDI) and a control group. For physical conditions, SDD group had 
significantly higher means in weight and BMI compared with the control group. The insulin and leptin levels in SHD 
group were significantly higher than those in the control group. The LDQ group showed marked decrease in mental 
condition scores compared with the control group. This study found that obese women in the SDD group were fatter 
than those in the control group. SHD group might have greater influence on the regulation of obesity-related hormone 
peptides. The LDQ group had poor QOL than the control group. Analysis of TCM syndrome groups among obese 
women merits further investigation. 
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Introduction
Obesity is becoming a global epidemic and an 
important health problem. Its prevalence has trebled 
since the 1980s, especially in developed countries. 
Many studies have shown association between obesity 
and other health problems including cardiovascular 
diseases, type-2 diabetes, sleep apnea, obesity-related 
cancers, osteoarthritis, and depression (Must et al., 
1999; Mokdad et al., 2003; Dixon, 2010).
Previous research also showed that our appetite and 
energy homeostasis were regulated by different obesity-
related hormone peptides, such as leptin, ghrelin, 
peptide YY3–36, adiponectin, resistin, and insulin 
(Flier and Maratos, 1998; Gale et al., 2004). In addition, 
there was also significant relationship between levels 
of obesity-related hormone peptides and QOL (Peyrot 
et al., 2011). Obesity not only influences a person’
s physiological conditions but also has a substantial 
negative impact on his/her QOL (Fine et al., 1999; 
Fontaine and Barofsky, 2001; Marchesini et al., 2003).
According to TCM theories, obese patients can be 
classified into different syndrome groups (證型 zhèng 
xíng) on the basis of their symptoms and according 
to the physician’s clinical experiences. Nevertheless, 
there is yet no standard approach to such classification. 
Hence, there is a need to develop a self-reported 
questionnaire on symptoms to facilitate the classification 
of  obese TCM syndrome groups.  In  addi t ion, 
understanding the relationship between obesity-related 
hormone peptides and QOL in different obese TCM 
syndrome groups can help TCM health workers provide 
better care to the patients. In view of the above, we 
conducted this cross-sectional study to explore the 
relationship between obesity-related hormone peptides 
and QOL in different obese TCM syndrome groups.   
Method
Study design and participants
This was a cross-sectional study conducted from 
January 2010 to December 2010 in Branch of Linsen 
and Chinese Medicine, Taipei City Hospital, Taiwan. Of 
572 obese women prescreened at our outpatient clinic, 
a total of 260 were enrolled. The inclusion criteria and 
exclusion criteria are shown in Table 1. The protocol 
was approved by the Human Ethics Committee of Taipei 
City hospital. 
Obese TCM syndrome groups and control group
The enrolled subjects were examined by TCM 
practitioners and diagnoses were made on the basis of 
the examination, symptoms reported by the patients 
and the practitioner’s experience. According to TCM 
concepts, our clinical experiences and related studies, 
five most common TCM syndrome groups of obese 
patients were defined (WHO, 2007; Zhu et al., 2010). 
These groups are respectively characterized by spleen 
deficiency with dampness encumbrance syndrome (脾
虛濕阻證 pí xū shī zǔ zhèng; SDD), stomach heat with 
dampness encumbrance syndrome (胃熱濕阻證 wèi rè 
shī zǔ zhèng; SHD), liver depression and qi stagnation 
syndrome (肝鬱氣滯證 gān yù qì zhì zhèng; LDQ), 
dual spleen-kidney deficiency syndrome (脾腎兩虛
證 pí shèn liǎng xū zhèng; SKD) and yin deficiency 
with internal heat syndrome (陰虛內熱證 yīn xū nèi rè 
zhèng; YDI). To our knowledge, there are no existing 
questionnaires or diagnostic tools for classifying 
obese patients. Hence, according to TCM concepts, 
we developed a self-reported questionnaire on patient 
symptoms as a diagnostic tool. Ten TCM doctors with 
clinical experience met and came up with four yes-no 
questions under each syndrome group for diagnosing 
obese patients. The questionnaire designed is shown in 
Table 2.
Obese patients with more than two symptoms 
reported for each syndrome in the questionnaire would 
be classified into that particular syndrome group. For 
patients with the same number of symptoms reported for 
more than one syndrome group, the classification would 
be made by the physician according to other information 
such as pulse and tongue appearance. 
The control group comprised patients not classified 
into any of the syndrome groups. Validation test results 
showed an alpha coefficient of 0.86 and Cronbach’s 
Table 1. Inclusion and Exclusion Criteria 
Inclusion Criteria
1. Female 
2. Age between 20 and 65 years old 
3. Body mass index ≧ 27 kg/m2 
4.  Willing to participate in and fill out the questionnaires for this trial 
Exclusion Criteria
1.  Endocrine diseases, e.g., thyroid disorder, pituitary disorder, and 
 sex gland disorder 
2.  Heart diseases, e.g., arrhythmia, heart failure, and myocardial 
 infarction, as well as patients with pacemaker 
3. Allergy and immunologic diseases 
4.  High aminotransferases (alanine, aspartate > 80 IU/L) or high 
 serum creatinine (> 2.5 mg/dL) 
5.  Pregnant or lactating or childbirth within 6 months 
6.  Stroke or otherwise unable to exercise 
7.  Management for weight control within 2 months 
8.  Any other conditions deemed unsuitable for trial as evaluated by 
 physician-in-charge 
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alpha coeff ic ient  of  0 .88,  indicat ing that  the 
questionnaire has good reliability.  
Quality of life 
To measure the QOL among our subjects, we used 
two self-administered QOL questionnaires. One 
was WHOQOL-BREF, Taiwan version which was 
well validated with consistency coefficients ranging 
from 0.70 to 0.77 (Yao et al., 2002). The WHOQOL-
BREF questionnaire evaluated QOL in physical, 
psychological, social and environmental domains, 
with scores ranging from 0 to 100. The other self-
administered QOL questionnaire we used was MOS 
Short Form-12 (SF-12). There are 12 items measuring 
eight concepts: physical functioning, role limitations 
due to physical health problems, bodily pain, general 
health, vitality, social functioning, role limitations due to 
emotional health, and mental health. Responses to these 
questions are transformed into two scores, physical 
condition score 12 (PCS-12) and mental condition score 
(MCS-12) , to reflect physical and mental conditions, 
respectively. The general population has a mean of 50 
and a standard deviation of 10 (Ware et al., 1996; Ware 
et al., 1998). Higher scores represent better health.
Analysis of obesity-related hormone peptides
The levels of obesity-related hormone peptides, 
including leptin, insulin, ghrelin and adiponectin, were 
measured in the morning after 8-9 hours of fasting. 
The whole blood sample was drawn and centrifuged at 
4℃, with 1 ml of the sample rapidly frozen at -80℃ 
for the subsequent radioimmunoassay concentration 
analysis. Leptin was detected by the Millipore Human 
Leptin assay (Millipore, St. Charles, MO, USA) using 
I125-labled human leptin antiserum with a sensitivity of 
0.5 ng/ml for a 100-μl sample. Ghrelin and adiponectin 
were detected by Millipore Ghrelin RIA Kits (Millipore, 
St. Charles) and Millipore Adiponectin RIA kits 
(Millipore, St. Charles) with a sensitivity of 93 pg/ml 
and 1ng/ml, respectively. We used the same process 
as that for leptin detection only with different I125-
labled antibodies specific for ghrelin or adiponectin. 
BioSource INS-IRMA Kits (BioSource Europe S.A., 
Nivelles, Belgium) were employed to determine the 
level of insulin in serum as previously reported (Starr 
et al., 1978; Agin et al., 2006). Sampling would be 
reported if a difference exceeding 10% CV was found 
between duplicated results of the sample. Following the 
approach of Matthews et al., we used the homeostasis 
model assessment for insulin resistance (HOMA-IR) for 
measuring insulin resistance of our subjects (Matthews 
et al. 1985).
Outcomes measurement
The major outcomes included the mean QOL 
scores and levels of obesity-related hormone peptides 
in different TCM syndrome groups and the control 
group. The outcomes were evaluated in terms of body 
weight, BMI and waist circumference, biochemical 
characteristics of blood sample including fasting blood 
sugar, triglyceride, total cholesterol levels, obesity-
related hormone peptides, and QOL scores on the 
WHOQOL-BREF and MOS Short Form-12 scores of 
different obese TCM syndrome groups classified by 
obese TCM questionnaire. All measurements were made 
after 8-9 hours of fasting using a standardized method, 
as detailed in our previous research (Hsu et al., 2008), 
and all participating physicians received prior training 
before the study on how to interview the patients and 
assist them in completing the questionnaires.
Statistical analysis
The data were analyzed using SPSS software (version 
17.0, Chicago, IL.) One-way ANOVA tests were 
Table 2. Questionnaire on traditional Chinese medicine syndrome 
groups 
In the past week, did you often have the following symptoms?
(Often means more than 8 hours per day and more than four days per 
week)
a.  Spleen deficiency with dampness encumbrance syndrome ( 脾 虛
濕阻證 pí xū shī zǔ zhèng; SDD)
(1) Leg pitting edema 
(2) Shortness of breath 
(3) Anorexia 
(4) Abdominal distention 
Yes
Yes
Yes
Yes
No
No
No
No
b.  Stomach heat with dampness encumbrance syndrome ( 胃熱濕阻
證 wèi rè shī zǔ zhèng; SHD)
(1) Swift digestion with frequent hunger 
(2) Aphthous stomatitis 
(3) Bitter taste in the mouth 
(4) Polydipsia 
Yes
Yes
Yes
Yes
No
No
No
No
c.  Liver depression and qi stagnation syndrome ( 肝鬱氣滯證 gān yù 
qì zhì zhèng; LDQ)
(1) Chest tightness 
(2) Insomnia 
(3) Agitation and irritability 
(4) Bitter taste in the mouth
Yes
Yes
Yes
Yes
No
No
No
No
d.  Dual spleen-kidney deficiency syndrome ( 脾 腎 兩 虛 證 pí shèn 
liǎng xū zhèng; SKD)
(1) Fear of cold 
(2) Lassitude in loin and legs 
(3) Frequent urination 
(4) Tinnitus and hard of hearing 
Yes
Yes
Yes
Yes
No
No
No
No
e.  Yin deficiency with internal heat syndrome ( 陰虛內熱證 yīn xū 
nèi rè zhèng; YDI)
(1) Night sweating 
(2) Dry throat and mouth 
(3) Lassitude in loin and legs 
(4) Aphthous stomatitis 
Yes
Yes
Yes
Yes
No
No
No
No
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employed to examine the means among obese women in 
different TCM syndrome groups. T-tests were employed 
to examine the difference in mean between the control 
group and other obese TCM syndrome groups. All 
p  values were two-tailed and considered statistically 
significant at α level of 0.05.
Results
Demographics and clinical features of participants
Among the 572 obese patients screened at our 
outpatient clinic, a total of 260 fulfilled with our 
inclusion and exclusion criteria and completed both 
questionnaires. The mean of age, weight, BMI, and 
waist circumference were 41.0 ± 11.5 years, 77.2 ± 11.6 
kg, 30.4 ± 4.0, 95.4 ± 9.4 cm, respectively.
Basic data 
Table 3 displays difference in basic data between 
the control group and different obese TCM syndrome 
groups. As can be seen, there was significant difference 
in weight and BMI between the SDD group and the 
control group; that is, obese patients with SDD were 
fatter than the control group.
Biochemical characteristics and obesity-related 
hormone peptides
As seen in Table 4, there was no significant difference 
in biochemical characteristics between the control group 
and the obese TCM syndrome groups. As for obesity-
related hormone peptides, both insulin and leptin levels 
were markedly higher in the SHD group than in the 
control group, while the ghrelin level of the SHD, LDQ, 
SKD, and YDI groups were significantly lower than that 
of the control group. The control group had the lowest 
insulin and leptin levels but the highest ghrelin level.   
QOL scores
As seen in Table 5, there was no difference in 
WHOQOL-BREF scores between the control and the 
obese TCM syndrome groups. With respect to SF-12 
QOL scores, there was significant difference in MCS-12 
score between the LDQ group and the control group, 
with obese patients having LDQ having the lowest MCS 
score.    
Discussion
Classification of TCM syndrome groups is an 
important guide for TCM physicians when choosing the 
treatment of choice for their patients. However, there 
has been little discussion on TCM syndrome groups 
among obese women. In the present study, among the 
five TCM syndrome groups, SDD and LDQ have higher 
prevalence, each accounting for 20% (52/260) of our 
obese subjects.
In terms of basic data, no significant difference was 
observed between the control group and the different 
obese TCM syndrome groups. Only the group with SDD 
showed higher body weight and larger BMI than the 
control group. According to TCM concepts, all obese 
patients have abnormal body weight, but the group with 
SDD seemed to have worse digestive function, which 
Table 3.Difference in basis data between control group and different obesity traditional Chinese medicine syndrome groups
Control SDDa SHDb LDQc  SKDd YDIe Total
Number (%) 26(10) 52(20) 45(17.3) 52(20) 51(19.6) 34(13.1) 260
Basic Data p-value
Age, years 43.1(10.9) 38.6(11.2) 38.9(12.2) 42.0(11.1) 42.5(10.6) 40.9(11.1) 0.30
Height, cm 158.1(5.0) 160.5(4.8) 159.2(5.9) 158.7(5.2) 158.5(5.5) 160.5(4.6) 0.17
Weight, kg 74.9(12.12) 82.8(13.9)** 79.7(13.7) 74.5(9.2) 73.8(8.5) 76.00(8.5) <0.001
Body mass index, kg/m2 29.9(3.9) 32.1(4.94)* 31.4(4.8) 29.5(2.9) 29.5(3.2) 29.5(2.5) 0.001
Waist circumference, cm 95.6(10.4) 96.5(10.3) 98.8(10.5) 94.3(8.9) 93.6(8.2) 93.5(6.5) 0.06
Hip circumference, cm 109.5(9.2) 112.4(10.3) 110.6(9.0) 107.7(6.5) 107.4(7.3) 107.8(5.9) 0.02
Systolic blood pressure , mmHg 136.1(22.5) 132.7(15.1) 136.6(18.7) 131.4(13.7) 130.2(17.6) 130.3(15.1) 0.23
Diastolic blood pressure , mmHg 79.2(12.2) 81.6(12.4) 81.6(12.9) 79.5(10.4) 79.6(8.2) 79.12(10.2) 0.78
Heart rate, times/min 78.2(9.4) 81.4(10.9) 78.7(12.9) 76.7(9.8) 79.2(9.1) 77.2(13.6) 0.37
The data are presented with mean (SD)
a, SDD = spleen deficiency with dampness encumbrance syndrome ( 脾虛濕阻證 pí xū shī zǔ zhèng)   b, SHD = stomach heat with dampness 
encumbrance syndrome ( 胃熱濕阻證 wèi rè shī zǔ zhèng)   c, LDQ = liver depression and qi stagnation syndrome ( 肝鬱氣滯證 gān yù qì zhì 
zhèng)   d, SKD = dual spleen-kidney deficiency syndrome ( 脾腎兩虛證 pí shèn liǎng xū zhèng)   e, YDI = yin deficiency with internal heat 
syndrome ( 陰虛內熱證 yīn xū nèi rè zhèng)
*p < 0.05, **p < 0.01, ***p < 0.001, vs. control group
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might account for the higher body weight and larger 
BMI than the control group. 
As seen in Table 4, there were statistically significant 
differences in insulin, leptin and ghrelin levels between 
the control group and the different obese TCM 
syndrome groups. Many obesity-related hormone 
peptides might regulate our appetite and energy 
homeostasis. Ghrelin, which is a hormone produced 
mainly by P/D1 cel ls  l ining the fundus of  the 
human stomach and epsilon cells of the pancreas that 
stimulates hunger (Inui et al. 2004). It is considered 
the counterpart of leptin, produced by adipose tissue, 
which induces satiation when present at higher levels. 
Obese patients tend to have decreased ghrelin levels 
but increased leptin levels, and the effects of ghrelin 
on energy homeostasis are opposite to those of leptin 
(Cummings et al., 2002; Zigman and Elmquist, 2003). 
In this study, we found the ghrelin level in obese 
Table 5.Quality of life scores of control group and different obesity traditional Chinese medicine syndrome groups
Control SDDa SHDb LDQc  SKDd YDIe Total
Number (%) 26(10) 52(20) 45(17.3) 52(20) 51(19.6) 34(13.1) 260
SF-12 QOL Scores p-value
PCS-12f 47.3(7.7) 44.7(7.4) 46.5(8.8) 47.0(7.1) 44.3(8.5) 47.1(7.1) 0.29
MCS-12g 48.5(11.6) 44.3(8.1) 45.0(8.5) 43.3(10.5)* 44.1(10.0) 49.0(7.1) 0.04
WHOQOL-BREF Scores
Physical 66.0(21.4) 62.1(12.3) 64.8(17.1) 65.4(13.1) 63.3(15.1) 70.6(10.7) 0.18
Psychological 75.3(18.9) 72.1(15.6) 72.1(11.8) 69.6(14.2) 71.6(17.7) 79.3(9.9) 0.08
Social 75.6(14.4) 71.9(12.2) 74.0(10.8) 73.0(10.2) 74.8(15.8) 78.7(11.0) 0.41
Environmental 76.0(15.8) 71.7(12.6) 73.6(12.1) 73.0(11.9) 73.9(15.8) 79.9(6.0) 0.08
The data are presented with mean (SD)
a, SDD = spleen deficiency with dampness encumbrance syndrome ( 脾虛濕阻證 pí xū shī zǔ zhèng)   b, SHD = stomach heat with dampness 
encumbrance syndrome ( 胃熱濕阻證 wèi rè shī zǔ zhèng)  c, LDQ = liver depression and qi stagnation syndrome ( 肝鬱氣滯證 gān yù qì zhì 
zhèng)   d, SKD = dual spleen-kidney deficiency syndrome  ( 脾腎兩虛證 pí shèn liǎng xū zhèng)  e, YDI = yin deficiency with internal heat 
syndrome ( 陰虛內熱證 yīn xū nèi rè zhèng)   f, PCS = physical condition score   g, MCS = mental condition score 
*p < 0.05, **p < 0.01, ***p < 0.001, vs. control group
Table 4. Biochemical characteristics and obesity-related hormone peptides of control group and different obesity traditional Chinese medicine 
syndrome groups
Control SDDa SHDb LDQc  SKDd YDIe Total
Number (%) 26(10) 52(20) 45(17.3) 52(20) 51(19.6) 34(13.1) 260
Biochemical Characteristics p-value
Glucose, mg/dl  99.5(14.6) 97.8(16.2) 99.2(17.8) 97.4(26.4) 108.2(48.3) 9.3(27.1) 0.44
Hemoglobin A1c , % 6.0(0.5) 5.9(0.9) 5.8(0.5) 5.8(0.4) 5.9(0.7) 5.6(0.4) 0.50
Creatinine, mg/dl 0.7(0.1) 0.8(0.1) 0.7(0.1) 0.7(0.1) 0.8(0.2) 0.7(0.1) 0.60
Alanine aminotransferase , U/l 30.5(25.8) 40.3(32.8) 34.4(27.0) 35.5(27.1) 29.5(17.3) 38.0(42.4) 0.49
Cholesterol, mg/dl 203.0(35.7) 205.7(35.1) 203.5(37.1) 200.4(31.3) 198.3(37.5) 199.6(30.3) 0.91
Triglyceride, mg/dl 129.8(59.0) 133.4(67.9) 145.0(77.9) 136.8(67.8) 130.7(59.9) 142.2(53.5) 0.88
HDL-Cf, mg/dl 47.5(11.7) 47.0(12.0) 52.1(11.6) 52.0(13.4) 49.3(11.7) 49.2(11.3) 0.20
LDL-Cg, mg/dl 127.2(42.3) 140.0(38.7) 121.2(34.7) 123.7(26.8) 127.2(35.4) 144.5(34.7) 0.12
Obesity-Related Hormone Peptides
Insulin, IU/ml 12.6(6.6) 13.6(8.1) 18.3(8.7)* 16.0(14.7) 14.5(10.9) 16.0(11.1) 0.23
Leptin, ng/ml 16.8(11.0) 19.3(9.2) 23.5(8.2)* 20.0(8.3) 19.1(8.9) 18.5(7.8) 0.04
Ghrelin, pg/ml 819.2(359.9) 747.6(315.9) 590.2(308.1)* 565.8(272.1)* 647.6(351.1)* 569.4(289.5)* 0.002
Adiponectin, ug/ml 20.8(6.3) 21.6(8.2) 21.2(3.3) 21.3(4.5) 20.5(5.6) 20.5(4.5) 0.89
HOMA-IR indexh 3.2(2.0) 3.3(2.5) 4.5(2.7) 3.9(3.7) 3.8(3.0) 3.8(2.6) 0.40
The data are presented with mean (SD)
a, SDD = spleen deficiency with dampness encumbrance syndrome ( 脾虛濕阻證 pí xū shī zǔ zhèng)   b, SHD = stomach heat with dampness 
encumbrance syndrome ( 胃熱濕阻證 wèi rè shī zǔ zhèng)   c, LDQ = liver depression and qi stagnation syndrome ( 肝鬱氣滯證 gān yù qì zhì 
zhèng)   d, SKD = dual spleen-kidney deficiency syndrome ( 脾腎兩虛證 pí shèn liǎng xū zhèng)   e, YDI = yin deficiency with internal heat 
syndrome ( 陰虛內熱證 yīn xū nèi rè zhèng)   f, HDL-C = high density lipoprotein cholesterol  
g, LDL-C = low density lipoprotein cholesterol  h, HOMA-IR = homeostasis model assessment for insulin resistance 
*p < 0.05, **p < 0.01, ***p < 0.001, vs. control group*p < 0.05, **p < 0.01, ***p < 0.001, vs. control group
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patients with SHD, LDQ, SKD and YDI lower than 
that in the control group. In addition, obese patients 
with SHD had higher insulin and leptin level compared 
with the control group.  Hence, we consider that SHD 
in obese patients might have greater influence on the 
regulation of obesity-related hormone peptides.     
In addition to influencing our pathological conditions, 
obesity has profound adverse physical,  social, 
economic consequences and environment that can 
negatively affect QOL (Marchesini et al., 2003; Jia and 
Lubetkin, 2005; Wee et al., 2008). To our knowledge, 
there was no study comparing QOL among different 
obese TCM syndrome groups. As seen in Table 5, 
there were statistically significant in trend with poor 
QOL in MCS-12 compare with the LDQ group and 
control group. Among them, obese patients with liver 
depression and qi stagnation syndrome have the lowest 
MCS-12 scores. These initial findings show that the 
diagnosis of LDQ might help physicians identify obese 
patients with poor QOL.   
The limitation of this study was that only four 
questions on symptoms experienced were designed for 
diagnosing or evaluating each obese TCM syndrome 
group; and hence, bias might exist. To our knowledge, 
there were no tools yet for detecting the different obese 
TCM syndrome groups. A self-reported symptom 
questionnaire was designed for this study as a diagnostic 
tool. Although validation was conducted, potential bias 
might exist.
In summary, obese patients with SHD in obese 
patients might have greater influence on the regulation 
of obesity-related hormone peptides, and obese patients 
diagnosed with LDQ have poor QOL. The concept 
of obese TCM syndrome diagnosis method might be 
applied to obesity health care. Related studies are worth 
more in-depth investigation in future. 
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